CoChat

A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

Open access

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index; 4 of the 31 sources its claims cite were checked for support.

Abstract

Pheochromocytomas are neural crest-derived tumors that arise from inherited or sporadic mutations in at least six independent genes. The proteins encoded by these multiple genes regulate distinct functions. We show here a functional link between tumors with VHL mutations and those with disruption of the genes encoding for succinate dehydrogenase (SDH) subunits B (SDHB) and D (SDHD). A transcription profile of reduced oxidoreductase is detected in all three of these tumor types, together with an angiogenesis/hypoxia profile typical of VHL dysfunction. The oxidoreductase defect, not previously detected in VHL-null tumors, is explained by suppression of the SDHB protein, a component of mitochondrial complex II. The decrease in SDHB is also noted in tumors with SDHD mutations. Gain-of-function and loss-of-function analyses show that the link between hypoxia signals (via VHL) and mitochondrial signals (via SDH) is mediated by HIF1alpha. These findings explain the shared features of pheochromocytomas with VHL and SDH mutations and suggest an additional mechanism for increased HIF1alpha activity in tumors.

Overview

CoChat Summary

TL;DR

This study links pheochromocytomas with VHL mutations to those with SDHB or SDHD mutations through a shared hypoxia/angiogenesis and reduced oxidoreductase expression signature. It proposes a HIF1α–SDHB regulatory loop in which HIF1α suppresses SDHB, impairing mitochondrial complex II and further stabilizing HIF1α.

Key findings

  • Unsupervised clustering of 76 primary pheochromocytomas/paragangliomas identified two dominant clusters: Cluster 1 contained all VHL and SDH tumors, while Cluster 2 contained all MEN2 and NF1 tumors; Cluster 1 included 12 of 13 extra-adrenal tumors, though more than half of Cluster 1 tumors were adrenal.
  • Cluster 1 tumors showed a hypoxia/angiogenesis signature plus coordinated suppression of oxidoreductase enzymes; supervised predictors distinguished MEN2 from VHL and MEN2 from SDH tumors with extensive gene overlap, and over 92% of the cohort was correctly assigned to one of the two classes.
  • SDHB protein was reduced in all tumors with SDH mutations and also suppressed in the majority of VHL-mutant and sporadic Cluster 1 tumors tested by immunoblot; SDHB immunostaining was highly concordant with immunoblot findings.
  • In cell models, cobalt chloride reduced SDHB protein, expression of nondegradable HIF1αP402A/P564A downregulated SDHB, and HIF1α shRNA prevented cobalt chloride–induced SDHB reduction, supporting HIF1α-dependent SDHB regulation.

Methods

  • Tumor specimens: 76 catecholamine-secreting pheochromocytomas or paragangliomas, including hereditary, familial undetermined, and sporadic tumors; 13 were extra-adrenal; no head/neck paragangliomas or SDHC-mutant tumors were included.
  • Expression profiling: 84 tumor samples including six replicates were hybridized to Affymetrix U133A arrays; after excluding four poor-quality scans, 76 unique tumors were analyzed using dChip normalization, unsupervised hierarchical clustering, supervised k-nearest neighbor and weighted-voting models, and GSEA.
  • Validation: DNA sequencing of RET, VHL, SDHD, SDHB, and SDHC in familial samples and 20 sporadic tumors; quantitative real-time PCR, Western blotting, immunohistochemistry, and cell-line experiments in HEK293, MPC 9/3L, and A2058 cells with cobalt chloride, HIF1α mutant, or HIF1α shRNA.

Limitations

  • The paper states that limited tumor material prevented quantitation of HIF1α and HIF2α protein levels in primary samples.
  • The paper states that HIF1α effects were less marked than those of hypoxia-mimetic agents, suggesting additional factors besides HIF1α may be involved in SDHB suppression, and that the precise mechanisms linking HIF1α and SDHB remain to be identified.
  • The paper notes that long-term follow-up was not available to precisely define one VHL family as VHL type 2C; evident from the text, the series excluded head/neck paragangliomas and SDHC-mutant tumors, and only 20 sporadic tumors were sequenced.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.0010008

Cites

44 of 45 references verified1 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Unsupervised Analysis of Pheochromocytomas Links Tumors with VHL and SDHB or SDHD Mutations Unsupervised hierarchical clustering identifies two major clusters in pheochromocytomas: Cluster 1 contains VHL (V), SDHD (D), and SDHB (B) tumors; Cluster 2 contains MEN2 (M) and NF1 (N) pheochromocytomas. Multiple tumors from seven independent unclassified families with recurrent pheochromocytoma (numbered 1–7) and also sporadic tumors (S) are distributed between the two clusters. Letters or numbers on the first row indicate the various tumor classes, as described above. The second row identifies tumor location as adrenal (A) or extra-adrenal (E). Mutations were later detected in samples marked with an asterisk, guided by cluster distribution (see text and Table 1 for details).
Figure 1 Unsupervised Analysis of Pheochromocytomas Links Tumors with VHL and SDHB or SDHD Mutations Unsupervised hierarchical clustering identifies two major clusters in pheochromocytomas: Cluster 1 contains VHL (V), SDHD (D), and SDHB (B) tumors; Cluster 2 contains MEN2 (M) and NF1 (N) pheochromocytomas. Multiple tumors from seven independent unclassified families with recurrent pheochromocytoma (numbered 1–7) and also sporadic tumors (S) are distributed between the two clusters. Letters or numbers on the first row indicate the various tumor classes, as described above. The second row identifies tumor location as adrenal (A) or extra-adrenal (E). Mutations were later detected in samples marked with an asterisk, guided by cluster distribution (see text and Table 1 for details).CC BY · PubMed Central
Figure 2 Similarity between VHL and SDH Tumors from Cluster 1 by Supervised Learning Methods Supervised analysis reveals an extensive overlap between genes that discriminate MEN2 from VHL (left) and MEN2 from SDH tumors (right). Samples are shown in columns and genes are represented in rows. Expression levels are normalized for each gene, where the mean is zero. Red indicates high-level expression and blue, low-level expression. The color scale at the bottom indicates relative expression and standard deviations from the mean. Some representative genes are displayed in a color-coded manner according to their functional classes (green, kinase receptor signaling and adrenergic metabolism; pink, oxidative response; blue, hypoxia-responsive/angiogenesis genes). Within each of these functional classes the order of gene appearance in the heat map has been maintained for each class comparison. Complete gene lists are available as Dataset S4.
Figure 2 Similarity between VHL and SDH Tumors from Cluster 1 by Supervised Learning Methods Supervised analysis reveals an extensive overlap between genes that discriminate MEN2 from VHL (left) and MEN2 from SDH tumors (right). Samples are shown in columns and genes are represented in rows. Expression levels are normalized for each gene, where the mean is zero. Red indicates high-level expression and blue, low-level expression. The color scale at the bottom indicates relative expression and standard deviations from the mean. Some representative genes are displayed in a color-coded manner according to their functional classes (green, kinase receptor signaling and adrenergic metabolism; pink, oxidative response; blue, hypoxia-responsive/angiogenesis genes). Within each of these functional classes the order of gene appearance in the heat map has been maintained for each class comparison. Complete gene lists are available as Dataset S4.CC BY · PubMed Central
Figure 3 Low Expression of SDHB Is a General Feature of Cluster 1 Tumors (A) Expression of SDHB protein in pheochromocytomas with SDHB or SDHD mutations. Western blot analysis of SDHB of whole cell lysates from primary tumors was performed as described in Methods. Lane 1 is normal adrenal medulla used as control and lanes 2–6 are tumors 140, 158, 136, 58, and 220, respectively, from Figure 1 and Table 1. β-actin was used as a loading control. (B) SDHB expression segregates with cluster membership. Cluster 2 tumors, comprising MEN2, NF1, and other sporadic tumors, are shown in lanes 2–4 (tumors 105, 91, and 196, respectively, from Figure 1). Cluster 1 contains tumors with VHL and SDHB mutations and a subset of sporadic samples (lanes 5–7 are tumors 16, 85, 101, and 152, respectively, from Figure 1). Lane 1 is normal adrenal medulla. β-actin was used as a loading control. (C) Immunostaining of SDHB protein in pheochromocytomas or paragangliomas with various genetic backgrounds. A MEN2-related pheochromocytoma is shown on the top row, followed by tumors with mutations in NF1, SDHB, SDHD, and VHL genes. Corresponding hematoxylin/eosin staining is shown on the left.
Figure 3 Low Expression of SDHB Is a General Feature of Cluster 1 Tumors (A) Expression of SDHB protein in pheochromocytomas with SDHB or SDHD mutations. Western blot analysis of SDHB of whole cell lysates from primary tumors was performed as described in Methods. Lane 1 is normal adrenal medulla used as control and lanes 2–6 are tumors 140, 158, 136, 58, and 220, respectively, from Figure 1 and Table 1. β-actin was used as a loading control. (B) SDHB expression segregates with cluster membership. Cluster 2 tumors, comprising MEN2, NF1, and other sporadic tumors, are shown in lanes 2–4 (tumors 105, 91, and 196, respectively, from Figure 1). Cluster 1 contains tumors with VHL and SDHB mutations and a subset of sporadic samples (lanes 5–7 are tumors 16, 85, 101, and 152, respectively, from Figure 1). Lane 1 is normal adrenal medulla. β-actin was used as a loading control. (C) Immunostaining of SDHB protein in pheochromocytomas or paragangliomas with various genetic backgrounds. A MEN2-related pheochromocytoma is shown on the top row, followed by tumors with mutations in NF1, SDHB, SDHD, and VHL genes. Corresponding hematoxylin/eosin staining is shown on the left.CC BY · PubMed Central
Figure 4 HIF1α Attenuates SDHB Levels (A) HIF1α expression was induced by treatment of mouse pheochromocytoma MPC 9/3L cells with 150 μM cobalt chloride for the indicated times. SDHB expression decreased in treated cells. Glut1 indicates increased activity of HIF1α, and β-actin was used as a loading control. (B) Transient expression in HEK293 cells of a HIF1α double mutant PA (P402A/P564A) that is resistant to VHL-mediated degradation reduced expression of SDHB. (C) A2058 cell lines stably expressing HIF1α shRNA do not show change in SDHB after cobalt chloride exposure, while SDHB is downregulated in control GFP shRNA cells treated with cobalt chloride. (D) Proposed model of HIF1α and SDHB interregulation. HIF1α downregulates SDHB, which leads to complex II dysfunction. High succinate levels resulting from loss of complex II, in turn, inhibit prolyl hydroxylase (PHD) activity [19]. Non-hydroxylated HIF1α is resistant to VHL-mediated targeting for degradation and can therefore activate downstream genes, such as angiogenic factors. “E3 complex” indicates the E3 ubiquitin ligase complex for which VHL is the substrate recognition factor.
Figure 4 HIF1α Attenuates SDHB Levels (A) HIF1α expression was induced by treatment of mouse pheochromocytoma MPC 9/3L cells with 150 μM cobalt chloride for the indicated times. SDHB expression decreased in treated cells. Glut1 indicates increased activity of HIF1α, and β-actin was used as a loading control. (B) Transient expression in HEK293 cells of a HIF1α double mutant PA (P402A/P564A) that is resistant to VHL-mediated degradation reduced expression of SDHB. (C) A2058 cell lines stably expressing HIF1α shRNA do not show change in SDHB after cobalt chloride exposure, while SDHB is downregulated in control GFP shRNA cells treated with cobalt chloride. (D) Proposed model of HIF1α and SDHB interregulation. HIF1α downregulates SDHB, which leads to complex II dysfunction. High succinate levels resulting from loss of complex II, in turn, inhibit prolyl hydroxylase (PHD) activity [19]. Non-hydroxylated HIF1α is resistant to VHL-mediated targeting for degradation and can therefore activate downstream genes, such as angiogenic factors. “E3 complex” indicates the E3 ubiquitin ligase complex for which VHL is the substrate recognition factor.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 1 Not valid · 19 Not checked · 72 Own results and interpretations

50 more claims

Create a free account to see all 94 claims and to verify the 27 references still open.

See all claims — free account
  • It may state two separate claims as one. 19
  • Probably not a substantial claim. 29

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 45 references

Cited by

See all 443

Metadata

Authors
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., Hodin, R., Heitritter, S., Moore, F., Dluhy, R., Sosa, J. A., Ocal, I. T., Benn, D. E., Marsh, D. J., Robinson, B. G., Schneider, K., Garber, J., Arum, S. M., Korbonits, M., Grossman, A., Pigny, P., Toledo, S. P. A., Nosé, V., Li, C., & Stiles, C. D.
Affiliations
  • Harvard University (US)
  • Broad Institute (US)
  • Universidade de São Paulo (BR)
  • Brigham and Women's Hospital (US)
  • Hospital General de Niños Ricardo Gutierrez (AR)
  • Tufts University (US)
  • Yale University (US)
  • The University of Sydney (AU)
  • Boston University (US)
  • St Bartholomew's Hospital (GB)
  • Université de Lille (FR)
Corresponding author
Dahia, Patricia L. M
Venue
PLoS Genetics
Published
2005-07-25
Volume
1
Issue
1
Pages
e8
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2093711185
Cited by
443
References
46
Citations by year
2026: 10 · 2025: 7 · 2024: 14 · 2023: 15 · 2022: 17 · 2021: 11 · 2020: 24 · 2019: 19 · 2018: 20 · 2017: 30 · 2016: 18 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 26
FWCI
17.50
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion, other-oa)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
Funders
  • Dana Foundation
  • Massachusetts General Hospital
  • National Institutes of Health (CA48017, HD 24926)
  • National Cancer Institute (R01CA048017)
  • National Institute of Neurological Disorders and Stroke (R01NS037685)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
Keywords
pheochromocytoma, HIF-1α, hypoxia, mitochondrial signaling, succinate dehydrogenase, SDHB, SDHD, VHL mutation, tumor angiogenesis, neural crest-derived tumors, transcriptional regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas. https://app.cochat.ai/papers/10.1371/journal.pgen.0010008
The paper
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., Hodin, R., Heitritter, S., Moore, F., Dluhy, R., Sosa, J. A., Ocal, I. T., Benn, D. E., Marsh, D. J., Robinson, B. G., . . . Stiles, C. D. (2005). A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas. PLoS Genetics. https://doi.org/10.1371/journal.pgen.0010008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.